Obesity Trial, Recruiting NCT06911073 Sponsor: ResBiotic Nutrition, Inc. Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT06911073
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are willing and able to give voluntary, signed, and dated consent to take part.
  • People who are in good general health based on their medical history.
  • People aged between 18 and 65 years (inclusive).
  • People with a Body Mass Index (BMI) between 25.0 and 40.0 (inclusive). BMI is a measure calculated from height and weight.
  • People who are willing to keep their usual eating habits and physical activity levels the same throughout the study.
  • People who are willing to stop taking any other probiotic or postbiotic supplements for the full duration of the trial.
  • People who are willing and able to follow all study procedures and requirements.
  • People who are able to read and complete questionnaires and carry out all study-related tasks.

Who may not be able to join:

  • People with a history of unstable or newly diagnosed heart, lung, liver, or kidney conditions.
  • People who have consumed more than 2 standard alcoholic drinks per day or more than 10 drinks per week, or who have had a drug or alcohol dependency, within the past 6 months.
  • People who have previously had weight-loss (bariatric) surgery.
  • People who currently smoke or have smoked within the past month.
  • People with a history of overactive parathyroid glands (hyperparathyroidism) or an untreated thyroid condition.
  • People who have had cancer in the past 5 years, with the exception of certain common skin cancers (basal cell or squamous cell skin cancer).
  • People with known gut or metabolic conditions that could affect how the body absorbs or processes nutrients — for example, irritable bowel syndrome (IBS), short bowel syndrome, a history of bowel surgery, chronic diarrhoea, gastroparesis, or inherited metabolic disorders such as PKU.
  • People with a long-term inflammatory condition, such as rheumatoid arthritis, Crohn's disease, ulcerative colitis, lupus, or HIV/AIDS.
  • People who have been diagnosed with gout or fibromyalgia.
  • Women who are pregnant, trying to become pregnant, less than 120 days post-birth, or currently breastfeeding. Sexually active women will need to report their pregnancy status before joining and again during the trial if they become pregnant.
  • People with a known allergy or sensitivity to any ingredient listed in the study product.
  • People who are currently taking part in another research study involving an investigational product, or who have taken part in such a study within the past 30 days.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ahmed Abdelgawad, MD, Able Biolabs, LLC

Phone: 617-634-3675

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
ResBiotic Nutrition, Inc.
Registry
ClinicalTrials.gov
Start date
2 May 2025
Est. completion
1 November 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

To determine the effect of resM™ on weight; To determine the effect of resM™ on BMI; To determine the effect of resM™ on food cravings; To determine the effect of resM™ on blood metabolic markers; To determine the effect of resM™ on blood metabolic markers; To determine the effect of resM™ on blood metabolic markers

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov